Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Status
- RECRUITING
- Phase
- PHASE1
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Nivolumab Based Immunotherapy for Treatment of High Grade Cervical Dysplasia
- Status
- WITHDRAWN
- Phase
- PHASE2
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
- Status
- UNKNOWN
- Phase
- PHASE1
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2